Oppenheimer & Co’s Cavium, Inc. CAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,243
Closed -$1.33M 1392
2017
Q3
$1.33M Buy
20,243
+14,359
+244% +$909K 0.04% 511
2017
Q2
$365K Buy
+5,884
New +$411K 0.01% 946
2016
Q2
Sell
-8,782
Closed -$537K 1346
2016
Q1
$537K Buy
8,782
+881
+11% +$50.9K 0.02% 727
2015
Q4
$519K Sell
7,901
-820
-9% -$55.3K 0.02% 754
2015
Q3
$535K Sell
8,721
-6,712
-43% -$447K 0.02% 781
2015
Q2
$1.06M Buy
15,433
+6,718
+77% +$471K 0.03% 610
2015
Q1
$617K Buy
+8,715
New +$566K 0.02% 792
2014
Q3
Sell
-8,435
Closed -$419K 1567
2014
Q2
$419K Buy
+8,435
New +$388K 0.01% 912

Other funds holding CAVM

Oppenheimer & Co's CAVM Position: Q4 2017 in Review

Oppenheimer & Co sold out of Cavium, Inc. (CAVM) in Q4 2017, closing a stake of 20,243 shares — an estimated $1.33M sold.

Oppenheimer & Co first reported a position in CAVM in Q2 2014 and held it in 8 quarters. The position peaked at $1.33M in Q3 2017. 264 funds tracked by Wall St. Rank hold CAVM as of Q4 2017.

  • Oppenheimer & Co reported no remaining Cavium, Inc. position as of Q4 2017 after selling out during the quarter.
  • Oppenheimer & Co sold 20,243 Cavium, Inc. shares in Q4 2017, an estimated $1.33M.
  • Oppenheimer & Co first reported a position in Cavium, Inc. in Q2 2014 and held it in 8 quarters.
  • Oppenheimer & Co's Cavium, Inc. position peaked at $1.33M in Q3 2017.
  • 264 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2017.

Based on Oppenheimer & Co's 13F filing for Q4 2017, filed 7 Feb 2018.